Protein M-based in vivo diagnostic system and detection method

A method comprising:

• (a) combining a solution with a nanoparticle conjugated to a complex, the complex comprising
• (i) antibodies labeled with a fluorophore, the labeled antibodies having target analyte binding sites;
• and
• (ii) protein M labeled with a quencher that is complimentary to the fluorophore of the labeled antibodies,
• wherein the labeled protein M competes with target analytes for the target analyte binding sites on the labeled antibodies;
• wherein the fluorophore and quencher are spectrally matched such that there is a detectable change in the fluorescent signal of the labeled antibodies when the fluorophore and the quencher are moved into or out of proximity to each other, and
• wherein fluorescent light levels change proportionately in response to the amount of target analytes that are able to bind with the labeled antibodies;
• and
• (b) measuring the fluorescence light level related to a presence of the target analytes in the solution.

A method comprising:

• introducing particles conjugated to complexes into the living body, the complexes comprising (i) antibodies labeled with a fluorophore, the labeled antibodies having target analyte binding sites;
• and (ii) protein M labeled with a quencher that is complimentary to the fluorophore of the labeled antibodies,
• wherein the labeled protein M competes with target analytes for the target analyte binding sites on the labeled antibodies;
• wherein the fluorophore and quencher are spectrally matched such that there is a detectable change in the fluorescent signal of the labeled antibodies when the fluorophore and the quencher are moved into or out of proximity to each other;
• wherein fluorescent light levels change proportionately in response to the amount of target analytes that are able to bind with the labeled antibodies;
• wherein the complexes are configured to bind with one or more target analytes, wherein presence or absence of the one or more target analytes in the living body is correlated with the biological state of the living body;
• detecting, by a wearable device mounted on an external surface of the living body, a signal transmitted from the living body, wherein the signal includes an analyte response signal that is related to binding of the one or more target analytes with the complexes;
• and
• determining a presence or absence of the one or more target analytes based on the analyte response signal.